TrialNature medicine2021

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.

Raffael Nachbagauer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.